Jonathan L Vennerstrom, PhD

Professor, Pharmaceutical Science

Phone402-559-5368

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Jonathan L Vennerstrom is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

6 Finished

Optimization of Antischistosomal Chemotypes
Vennerstrom, J. L.
National Institutes of Health
2/1/15 → 1/31/20
Project: Research project
Leveraging RC-12 for Radical Cure of Plasmodium Vivax
Vennerstrom, J. L.
National Institutes of Health
2/1/13 → 1/31/16
Project: Research project
Increasing the Antischistosomal Selectivity of Aryl Hydantoins
Vennerstrom, J. L.
National Institutes of Health
8/15/12 → 7/31/15
Project: Research project
Trematocidal Synthetic Perioxides
Vennerstrom, J. L.
National Institutes of Health
7/15/08 → 12/30/10
Project: Research project
METABOLIC STABILITY IN ANTIMALARIAL TETRAOXANES
Vennerstrom, J. L.
National Institutes of Health
6/1/96 → 5/31/00
Project: Research project

6409 Citations
47 h-Index
126 Article
5 Review article
2 Chapter
1 Comment/debate
More
- 1 Short survey

In vitro selection implicates rop1 as a resistance gene for an experimental therapeutic benzoquinone acyl hydrazone in toxoplasma gondii
Martens, M. C., Won, M. M., Won, H. I., Schulze, T. T., Judge, A. K., Neville, A. J., Vennerstrom, J. L. & Davis, P. H., Mar 2021, In: Antimicrobial Agents and Chemotherapy. 65, 3, e01040-20.
Research output: Contribution to journal › Article › peer-review
A new chemotype with promise against Trypanosoma cruzi
Wang, X., Cal, M., Kaiser, M., Buckner, F. S., Lepesheva, G. I., Sanford, A. G., Wallick, A. I., Davis, P. H. & Vennerstrom, J. L., Jan 1 2020, In: Bioorganic and Medicinal Chemistry Letters. 30, 1, 126778.
Research output: Contribution to journal › Article › peer-review
Efficacy, metabolism and pharmacokinetics of Ro 15-5458, a forgotten schistosomicidal 9-Acridanone hydrazone
Probst, A., Häberli, C., Siegel, D., Huang, J., Vigneron, S., Ta, A. P., Skinner, D. E., El-Sakkary, N., Momper, J. D., Gangoiti, J., Dong, Y., Vennerstrom, J. L., Charman, S. A., Caffrey, C. R. & Keiser, J., Oct 1 2020, In: Journal of Antimicrobial Chemotherapy. 75, 10, p. 2925-2932 8 p.
Research output: Contribution to journal › Article › peer-review
Ligand-based design of GLUT inhibitors as potential antitumor agents
Almahmoud, S., Jin, W., Geng, L., Wang, J., Wang, X., Vennerstrom, J. L. & Zhong, H. A., Apr 1 2020, In: Bioorganic and Medicinal Chemistry. 28, 7, 115395.
Research output: Contribution to journal › Article › peer-review
4 Scopus citations
Structure-Activity Relationship of Antischistosomal Ozonide Carboxylic Acids
Wu, J., Wang, X., Chiu, F. C. K., Häberli, C., Shackleford, D. M., Ryan, E., Kamaraj, S., Bulbule, V. J., Wallick, A. I., Dong, Y., White, K. L., Davis, P. H., Charman, S. A., Keiser, J. & Vennerstrom, J. L., Apr 9 2020, In: Journal of Medicinal Chemistry. 63, 7, p. 3723-3736 14 p.
Research output: Contribution to journal › Article › peer-review
3 Scopus citations